@Rad_Nation @ElenaSperk A manuscript is under review which will describe the results as per subgroups. I so wish we could divulge the information. We are currently focussing on the discussion of the published paper. #radonc #jc https://t.co/WvCo6ZpKws
@Rad_Nation @ElenaSperk The dosimetry is very different from HDR brachytherapy – cannot be explained easily on twitter. Most importantly, the dose rate and energy is lower with TARGIT-IORT. The ultimate test is outcome in a randomised trial. #radonc #jc ht
@Rad_Nation @ElenaSperk The anaesthetist & radiation physics team monitor behind lead shields/ a window to the OR; others may go have a coffee. Once TARGIT-IORT is completed, the applicator is removed followed by careful surgical closure of the wound.
@Rad_Nation @ElenaSperk A2: If one now believes that ‘no tumour on ink’ is no worse than 1mm margin, then we could reasonably accept a ‘a negative margin’ as adequate enough to avoid supplemental EBRT. https://t.co/WvCo6ZpKws https://t.co/0aGrKqb9Xt #rado
RT @BreastDocUK: For those wanting a quick intro into today's #radonc #jc topic of IORT in the TARGIT study I recommend the 4min video abst…
RT @Rad_Nation: Here is the blog post for #radonc #jc: https://t.co/itbJ8DVDi9 Article: https://t.co/HWpc9o4AU4 https://t.co/248eP1B76x
RT @jsvaidya: @Rad_Nation The control was whole breast radiotherapy to all patients; it was compared with risk adapted radiotherapy. ‘Risk-…
@Rad_Nation These included unsuspected lobular carcinoma, extensive intraductal component, or positive margins – which could be markers for more infiltrative tumours. We expected that these would be present in 15-20% of cases. #radonc #jc #bcsm https://t.
@Rad_Nation The control was whole breast radiotherapy to all patients; it was compared with risk adapted radiotherapy. ‘Risk-adapted’ because some characteristics could confer a higher risk of recurrence far from tumour bed #radonc #jc #bcsm https://t.co/
RT @Rad_Nation: Here is the blog post for #radonc #jc: https://t.co/itbJ8DVDi9 Article: https://t.co/HWpc9o4AU4 https://t.co/248eP1B76x
RT @BreastDocUK: For those wanting a quick intro into today's #radonc #jc topic of IORT in the TARGIT study I recommend the 4min video abst…
Here is the blog post for #radonc #jc: https://t.co/itbJ8DVDi9 Article: https://t.co/HWpc9o4AU4 https://t.co/248eP1B76x
RT @BreastDocUK: For those wanting a quick intro into today's #radonc #jc topic of IORT in the TARGIT study I recommend the 4min video abst…
RT @BreastDocUK: For those wanting a quick intro into today's #radonc #jc topic of IORT in the TARGIT study I recommend the 4min video abst…
For those wanting a quick intro into today's #radonc #jc topic of IORT in the TARGIT study I recommend the 4min video abstract provided with the paper here: https://t.co/5TdkSsDQYc A good initiative in science comms from @bmj_latest https://t.co/niYSORWx
RT @tdcil: Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IO…
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ https://t.co/ZPupaevMA1
@Rad_Nation @DrAttai @tbjulian @abigailcaudle @JenniferPlichta @DrYaraRobertson @DianeRadfordMD @Dr_Dana @MehraGolshan Article is now free to access at @bmj_latest https://t.co/ykRvLpLWWd. Questions in blog post link above FYI @DrHBurstein @tmprowell @Dr
RT @OWise_uk: A recent trial has demonstrated that for early #breastcancer, an immediate single-dose radiotherapy dose during lumpectomy wa…
@subatomicdoc @devnani_bharti @Nani6016 @EmanDuhaiby @nuradh @pre_rad @ElenaSperk @IBCradiation @reshmajagsi @fumikochino @AshleyAlbertMD @ChelainG @bmj_latest ah, I am seeing now... between this: https://t.co/XzdTB4Ib44 where the LRR at 5 years =CALGB 934
FYI @SueEvansMDMPH @devnani_bharti @Nani6016 @EmanDuhaiby @nuradh @pre_rad @ElenaSperk @IBCradiation @reshmajagsi @fumikochino @AshleyAlbertMD @ChelainG This weekend we're discussing TARGIT-A. Article free here @bmj_latest https://t.co/ykRvLpLWWd #bcs
Intraoperative radiotherapy with addition of preoperative chemoimmunotherapy during COVID 19 for all solid tumor to compare with standard treatment
RT @LobularBCA: Partial or local #radonc is being studied for #breastcancer but routinely either exclude #lobular or include low samples. T…
RT @Maherjane: I’ve always had niggling doubts about this ( not sure why ) but data is data - what do others think now ? @SorenBentzen @Bre…
RT @SorenBentzen: @fumikochino @subatomicdoc @Maherjane @BreastDocUK @cpeedell @HannahT_85 @MylinTorres @BenSmithMD There are SO many issue…
RT @SorenBentzen: @fumikochino @subatomicdoc @Maherjane @BreastDocUK @cpeedell @HannahT_85 @MylinTorres @BenSmithMD There are SO many issue…
@subatomicdoc @subatomicdoc - I hope Soren joins in the discussion
RT @bmj_latest: Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discus…
RT @bmj_latest: Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discus…
@fumikochino @subatomicdoc @Maherjane @BreastDocUK @cpeedell @HannahT_85 @MylinTorres @BenSmithMD There are SO many issues with the design, analysis, and interpretation of TARGIT. These were raised immediately after the original publication and dampened th
RT @bmj_latest: Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discus…
RT @bmj_latest: Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discus…
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
#BestStudyoftheDay: Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer https://t.co/tU4EqrbulV – BMJ - #breast #cancer #oncology #radiotherapy
RT @CMI_UCL: Massive congratulations to Chris Brew-Graves on being part of the BMJ Radiotherapy trial! 'Long term survival and local contro…
RT @jsvaidya: @ElenaSperk Indeed. TARGIT-IORT reduced the social and environmental impact on patients undergoing treatment for #breastcanc…
@dr_xrt Indeed. TARGIT-IORT greatly reduced the social and environmental impact on patients undergoing treatment for #breastcancer as seen in this paper: https://t.co/4gTpYdFDUU The long-term results of TARGIT-IORT during lumpectomy: https://t.co/B7EsfQvg
@ElenaSperk Indeed. TARGIT-IORT reduced the social and environmental impact on patients undergoing treatment for #breastcancer as seen in this paper: https://t.co/4gTpYdFDUU The long-term results of TARGIT-IORT during lumpectomy: https://t.co/WvCo6ZpKws
@CMI_UCL You can download the full paper at https://t.co/WvCo6ZpKws
RT @CMI_UCL: Massive congratulations to Chris Brew-Graves on being part of the BMJ Radiotherapy trial! 'Long term survival and local contro…
RT @CMI_UCL: Massive congratulations to Chris Brew-Graves on being part of the BMJ Radiotherapy trial! 'Long term survival and local contro…
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/XCuPwlQYia
Single dose radiotherapy as good as conventional radiotherapy for most women with early breast cancer: full paper at https://t.co/WvCo6ZpKws
TARGIT: radioterapia intraoperatoria no inferior a la convencional, ensayo clínico aleatorizado. Opción para tratar el #cancerdemama en un solo día, pero se precisa quirófano específico para radioterapia. https://t.co/TXDEMusPax @bmj_company https://t.co/o
RT @CMI_UCL: Massive congratulations to Chris Brew-Graves on being part of the BMJ Radiotherapy trial! 'Long term survival and local contro…
Massive congratulations to Chris Brew-Graves on being part of the BMJ Radiotherapy trial! 'Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy...' 👇 👇 https://t.co/ZlV5DU0lC0
RT @MamMa_mimumemo: BMJから。 乳房温存療法の放射線治療で、術中照射 vs 通常の外照射の非劣性試験。 局所再発や乳がん死などは同等。 非乳がん死は、術中照射の方が少ない結果に。心血管イベントなどが想定されるけど、1999年開始の試験だし解釈難しい。術中照…
RT @MamMa_mimumemo: BMJから。 乳房温存療法の放射線治療で、術中照射 vs 通常の外照射の非劣性試験。 局所再発や乳がん死などは同等。 非乳がん死は、術中照射の方が少ない結果に。心血管イベントなどが想定されるけど、1999年開始の試験だし解釈難しい。術中照…
RT @MamMa_mimumemo: BMJから。 乳房温存療法の放射線治療で、術中照射 vs 通常の外照射の非劣性試験。 局所再発や乳がん死などは同等。 非乳がん死は、術中照射の方が少ない結果に。心血管イベントなどが想定されるけど、1999年開始の試験だし解釈難しい。術中照…
RT @MamMa_mimumemo: BMJから。 乳房温存療法の放射線治療で、術中照射 vs 通常の外照射の非劣性試験。 局所再発や乳がん死などは同等。 非乳がん死は、術中照射の方が少ない結果に。心血管イベントなどが想定されるけど、1999年開始の試験だし解釈難しい。術中照…
RT @MamMa_mimumemo: BMJから。 乳房温存療法の放射線治療で、術中照射 vs 通常の外照射の非劣性試験。 局所再発や乳がん死などは同等。 非乳がん死は、術中照射の方が少ない結果に。心血管イベントなどが想定されるけど、1999年開始の試験だし解釈難しい。術中照…
BMJから。 乳房温存療法の放射線治療で、術中照射 vs 通常の外照射の非劣性試験。 局所再発や乳がん死などは同等。 非乳がん死は、術中照射の方が少ない結果に。心血管イベントなどが想定されるけど、1999年開始の試験だし解釈難しい。術中照射の日常運用は非現実的すぎだし… https://t.co/0EHel0ZqqD
RT @LobularBCA: Partial or local #radonc is being studied for #breastcancer but routinely either exclude #lobular or include low samples. T…
RT @LobularBCA: Partial or local #radonc is being studied for #breastcancer but routinely either exclude #lobular or include low samples. T…
RT @LobularBCA: Partial or local #radonc is being studied for #breastcancer but routinely either exclude #lobular or include low samples. T…
RT @LobularBCA: Partial or local #radonc is being studied for #breastcancer but routinely either exclude #lobular or include low samples. T…
RT @LobularBCA: Partial or local #radonc is being studied for #breastcancer but routinely either exclude #lobular or include low samples. T…
RT @LobularBCA: Partial or local #radonc is being studied for #breastcancer but routinely either exclude #lobular or include low samples. T…
Partial or local #radonc is being studied for #breastcancer but routinely either exclude #lobular or include low samples. This study is #IDC only. Patients with #lobular need specific guidance. #bcsm @oncoalert @astro-org https://t.co/rClnZtuzdX
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
RT @bmj_latest: For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conv…
For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just as effective as conventional radiotherapy, suggest new research findings https://t.co/KYLzGxQjrO @jsvaidya
RT @targitcg: Very exciting news!!
Very exciting news!!
RT @jsvaidya: When considering no-radiotherapy instead of TARGIT-IORT, patients should be informed of these data. https://t.co/dn6N2OVFPb h…
Congratulations to the researchers & institutions who participated in the TARGiT-A intraoperative radiotherapy clinical trial for the publication of the long-term results in the BMJ. Thank you for your relentless work in pursuit of advancements in wome
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @DrLauraEsserman: An important step forward to reducing treatment burden for women with breast cancerSingle dose of radiation In the ope…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
La radioterapia intraoperatoria (regional/una dósis) ofrece resultados comparables a la externa (en varias semanas) en pacientes con #cáncerdemama temprano sometidas a cirugía conservadora. #Prosama #BreastcancerMéxico https://t.co/4dWKoPSdHE
RT @pash22: Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-I…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…